Merge Cardio software. Product Usage: Merge Cardio is a system intended to be used to acquire, store, print, transfer, and archive clinical information including images, Hemodynamic studies and reports, measurements (via import from DICOM Structured Reporting, text files or optical character recognition of measurements captured on images) and cardiology signal (waveform) data.
Published March 29, 2017 · Recall initiated: September 22, 2015
Summary
FDA records medical device Class II recall Z-1517-2017, published March 29, 2017 and initiated September 22, 2015. Recalling firm: Merge Healthcare, Inc.; Status: Terminated; Reported quantity: 89 sites potentially have the affected software; Lot: Versions 9.0, 9.0.1, 9.0.2, 9.0.3, 9.0.4, 9.0.5, 9.0.6, 9.0.7, and 9.0.8. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Users can merge a device import file with an image study that already has a confirmed report, which may result in including information not present at the time of physician interpretation.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Merge Healthcare, Inc.
- Distributor
- US Nationwide Distribution.
- Lot
- Versions 9.0, 9.0.1, 9.0.2, 9.0.3, 9.0.4, 9.0.5, 9.0.6, 9.0.7, and 9.0.8
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAMerge PACS and Merge OrthoPACS, medical imaging diagnostic workstationSeptember 2, 2026
- FDAMerge OrthoPACS, medical imaging diagnostic workstationAugust 12, 2026
- FDAMerge PACS, medical imaging diagnostic workstationAugust 12, 2026
- FDAVERICIS, Merge Cardio, Model/Catalog Number: Version 9.x, Software Version: 9.0.6 and 9.0.8; VERICIS is anMarch 26, 2025
- FDAPoly Component Trial, UCCS, packaged in the following sizes and configurations: a) Poly Comp Trial - UCCSMarch 29, 2017
- FDAETEST Ceftazidime TZ256 Foam packaging, Product Name: ETEST Ceftazidime TZ 0.016-256. ETEST is a quantitativeMarch 29, 2017
Questions about this recall
Was Merge Cardio software. Product Usage: Merge Cardio is a system intended to be used to acquire, store, print, transfer, and archive clinical information including images, Hemodynamic studies and reports, measurements (via import from DICOM Structured Reporting, text files or optical character recognition of measurements captured on images) and cardiology signal (waveform) data. recalled?
Yes. FDA published recall Z-1517-2017 on March 29, 2017. Reported hazard: Users can merge a device import file with an image study that already has a confirmed report, which may result in including information not present at the time of physician interpretation.
What should I do if I have this product?
Voluntary: Firm initiated · Letter